Text Size
368 studies found for:    "Lupus Erythematosus, Systemic"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"Lupus Erythematosus, Systemic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: epratuzumab
2 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
3 Completed Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
Conditions: Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention: Drug: Dehydroepiandrosterone
4 Recruiting Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid
Intervention:
5 Terminated Physical Therapy for Systemic Lupus Erythematosus (SLE)
Conditions: Lupus Erythematosus, Systemic;   SLE
Intervention: Behavioral: Physical Therapy or Relaxation Therapy
6 Active, not recruiting Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Biological: Rituxan (rituximab);   Biological: filgrastim;   Drug: methylprednisolone;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation
7 Unknown † Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
8 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: Cyclophosphamide
9 Enrolling by invitation An Open-label Study to Evaluate the Long-term Safety of MEDI-546, a Product Under Investigation for the Treatment of Systemic Lupus Erythematosus, in Adults
Condition: Lupus Erythematosus, Systemic
Intervention: Biological: MEDI-546
10 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo
11 Recruiting Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo
12 Completed Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Intervention: Drug: tacrolimus
13 Unknown † Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
14 Active, not recruiting Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
15 Completed Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
Conditions: Lupus Erythematosus, Systemic;   Adverse Effects
Interventions: Genetic: Polymorphism Analysis;   Drug: Cyclophosphamide;   Other: Pharmacokinetic analysis
16 Active, not recruiting Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: Prevenar® and Pneumo23®;   Biological: Placebo, Pneumo23®
17 Completed Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: SBI-087
18 Recruiting Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
Conditions: Immune System Diseases;   Autoimmune Diseases;   Lupus Erythematosus, Systemic;   Skin and Connective Tissue Diseases;   Connective Tissue Disease
Interventions: Biological: CDP7657;   Other: Placebo
19 Active, not recruiting
Has Results 		A Study to Evaluate the Efficacy and Safety of Rituximab in Patients With Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: placebo;   Drug: prednisone;   Drug: rituximab
20 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years